openPR Logo
Press release

Advanced Therapies - Marketing Authorisation of ATMPs - Tasks for CAT

08-29-2008 03:19 PM CET | Science & Education

Press release from: FORUM Institute of Management

For the first time, all "advanced therapies" (gene therapy, somatic cell therapy and tissue engineering products) will be centralised in a single procedure of the newly adopted European Regulation No 1394/2007 ("the Regulation") on advanced therapy medicinal products (ATMPs). This regulation lays down specific
rules concerning the authorisation, supervision and pharmacovigilance of ATMPs and will apply as of 30 December 2008.

The focus of this seminar will be on the required legitimate and regulatory framework regarding ATMP research, authorisation and manufacturing.

FORUM Institute fuer Management, one of the leading professional seminar and conference providers in Europe, offers the seminar "Advanced Therapies - Marketing Authorisation of ATMPs - Tasks for CAT" for the pharmaceutical industry on 9 December 2008 in Frankfurt am Main.
Further information on the seminar and the company you will find under:
http://www.forum-institut.de/veranstaltung.asp?SemNr=0809236

Contact:
Dr. Nadine Jede
Conference Manager
Department Pharma
FORUM Institut fuer Management GmbH, Heidelberg
Vangerowstraße 18
69115 Heidelberg
Germany
Tel. +49 6221 500 655
Fax. +49 6221 500 618
n.jede@forum-institut.de

FORUM Institute is very active and acknowledged in the field of educational seminars and conferences for the pharmaceutical industry. In several areas FORUM has the leading market position. Especially the close co-operation with the regulatory authorities assures the outstanding quality and up-to-dateness of the trainings. Each novel important guideline from the national authorities or the EMEA/CHMP results in a seminar within a short period of time to insure that pharmaceutical industry personnel receives the proper information and training. The speakers are experts from the pharmaceutical industry, service provider, lawyers and national / international authorities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advanced Therapies - Marketing Authorisation of ATMPs - Tasks for CAT here

News-ID: 52282 • Views: 1191

More Releases from FORUM Institute of Management

Step by step through Medical Device Law
Which laws apply to a clinical trial by medical devices? Which forms of advertising are permitted? Under which circumstances is the manufacturer liable? And when is the user? The current 4th amendment of the German Medical Device Act (MPG) and the associated new requirements for manufacturers. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of discussions. FORUM Institute fuer Management,
Quality Documentation of Medicinal Substances incorporated in Medical Devices
In order to demonstrate appropriate quality for incorporated medicinal substances in medical devices (ancillary medicinal substances), applicants need to provide information and scientific data, which are similar to that requested by authorithies for API"s in medicinal products. These data are submitted to the competent authorities by the notified body involved. FORUM Institut für Management extend to this tender subject an intensive seminar. The attendant limiting allows great deal of
The safety inspector for medical device
Every medical device company had to reappoint somebody to the safety inspector of medical devices. This positon comprised a great accountability with personal liability in the field of the company and also to the user. The safety inspector for medical device is bound to procedural requirements. The postion proceed an important role in the risk management. Das FORUM Institut für Management extend to this tender subject an
Marketing Authorisation in Europe 2009
2007/2008 have brought many changes in the field of regulatory affairs. 2009 casts its shadow ahead. - What kind of changes does the revision of the EU guidance on the SmPC bring? - What is the current status of the new variation regulation? - The paperless eCTD - is it a reality coming soon? - Sunset clause - are all questions answered? FORUM Institute fuer Management, one of the leading professional seminar and conference providers

All 5 Releases


More Releases for ATMP

Advanced Therapy Medicinal Product (ATMP) Manufacturing Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Advanced Therapy Medicinal Product (ATMP) Manufacturing Market is projected to grow from USD 9.37 billion in 2022 to USD 22.48 billion at a CAGR value of 12.8% from 2022 to 2027. The growing investment in the development of novel gene therapy-based cancer treatments, the growing availability of cell therapy in the market, the growing investment in
Pharmaceutical Isolator Market In-deep Analysis And Experts Review Report 2019-2 …
The report titled "Pharmaceutical Isolator Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts. The Pharmaceutical Isolator market was
Exclusive Speaker Interview for SMI’s Inaugural Cell & Gene Therapy 2018
SMi are delighted to have interviewed, speaker, Ioannis Papantoniou, ATMP Bioprocessing Coordinator, Skeletal Biology and Engineering Research Centre, KU Leuven regarding his thoughts and experiences within the cell & gene therapy space. Ioannis Papantoniou is a Chemical Engineer by training, at the University of Patras, Greece. After graduation he pursued a Doctoral degree (MPhil and PhD) at the Department of Biochemical Engineering, University College London (UCL), UK. He carried out his
Phosphonate Market Report for Period 2017 till 2022 Shandong Taihe Water Treatme …
Global Phosphonate market report provides detailed analysis of companies namely WW Group, Changzhou Kewei Fine Chemicals, Excel Industries, Manhar Specaalities, Shandong Xintai Water Treatment Technology, Zaozhuang Kerui Chemicals, Changzhou Yuanquan Hongguang Chemical, Yichang Kaixiang Chemical, Italmatch Chemicals, Aquapharm Chemicals, Zeel Product, Qingshuiyuan Technology, Shandong Taihe Water Treatment Technologies, Jianghai Environmental Protection and Others. This report study includes global market statistics and analysis for example, company performance, historical analysis 2012 to
Global Phosphonate Market: Scenario 2022
September Offer - Flat 20% discount on purchase of this report from 15th to 30th September @ https://www.researchtrades.com/discount/1001070 For more offers post 30th September, kindly contact us. Contact No. : +16269994607 (US)/ +91 7507349866 (IND) Email: sales@researchtrades.com Report Overview: The “Global Phosphonate Market Research Report” is a professional and in-depth study on the current state of the Phosphonate Market. The study offers an insight into current and future market trends, key drivers and restraints, market
Phosphonate Market Professional Survey Capacity, Production and Share by Manufac …
Phosphonates are a class of chelating agents and scale inhibitors, which structurally have the phosphonic acid group �PO3H2 in common. They are used in household cleaning products, personal care products, institutional cleaners and industrial cleaning processes, and as water treatment additives in various applications. The most common phosphonates are aminotris(methylene phosphonic acid) (ATMP), 1-hydroxyethylidene diphosphonic acid (HEDP) and diethylenetriamine penta(methylene phosphonic acid (DTPMP). Scope of the Report: This report focuses on the